Intermittent hypoxia induces the proliferation of rat vascular smooth muscle cell with the increases in epidermal growth factor family and erbB2 receptor

Experimental Cell Research

Volumn 319, Issue 19, 2013, Pages 3042-3050

  Kyotani, Yoji ^a,b   Ota, Hiroyo ^a   Itaya Hironaka, Asako ^a   Yamauchi, Akiyo ^a   Sakuramoto Tsuchida, Sumiyo ^a   Zhao, Jing ^a   Ozawa, Kentaro ^a   Nagayama, Kosuke ^a   Ito, Satoyasu ^a   Takasawa, Shin ^a   Kimura, Hiroshi ^a   Uno, Masayuki ^b   Yoshizumi, Masanori ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Epidermal growth factor; ErbB2 receptor; Intermittent hypoxia; Vascular smooth muscle cell

Indexed keywords

AMPHIREGULIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIREGULIN; NEU DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; INTERMITTENT HYPOXIA; INTRACELLULAR SIGNALING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

RATTUS;

EID: 84886589476     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.08.014     Document Type: Article

References (34)

1. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 1993, 328:1230-1235.
2. Nieto F.J., Young T.B., Lind B.K., Shahar E., Samet J.M., Redline S., D'Agostino R.B., Newman A.B., Lebowitz M.D., Pickering T.G. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study JAMA 2000, 283:1829-1836.
3. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med. 2000, 342:1378-1384.
4. Shahar E., Whitney C.W., Redline S., Lee E.T., Newman A.B., Nieto F.J., O'Connor G.T., Boland L.L., Schwartz J.E., Samet J.M. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med. 2001, 163:19-25.
5. Drager L.F., Bortolotto L.A., Lorenzi M.C., Figueiredo A.C., Krieger E.M., Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 2005, 172:613-618.
6. Drager L.F., Bortolotto L.A., Figueiredo A.C., Krieger E.M., Lorenzi G.F. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am. J. Respir. Crit Care Med. 2007, 176:706-712.
7. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
8. Doherty L.S., Kiely J.L., Swan V., McNicholas W.T. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005, 127:2076-2084.
9. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
10. Kyotani Y., Zhao J., Tomita S., Nakayama H., Isosaki M., Uno M., Yoshizumi M. Olmesartan inhibits angiotensin II-induced migration of vascular smooth muscle cells through Src and mitogen-activated protein kinase pathways. J. Pharmacol. Sci. 2010, 113:161-168.
11. Ota H., Tamaki S., Itaya-Hironaka A., Yamauchi A., Sakuramoto-Tsuchida S., Morioka T., Takasawa S., Kimura H. Attenuation of glucose-induced insulin secretion by intermittent hypoxia via down-regulation of CD38. Life Sci. 2012, 90:206-211.
12. Kobayashi S., Akiyama T., Nata K., Abe M., Tajima M., Shervani N.J., Unno M., Matsuno S., Sasaki H., Takasawa S., Okamoto H. Identification of a receptor for Reg (regenerating gene) protein, a pancreatic β-cell regeneration factor. J. Biol. Chem. 2000, 275:10723-10726.
13. Akiyama T., Takasawa S., Nata K., Kobayashi S., Abe M., Shervani N.J., Ikeda T., Nakagawa K., Unno M., Matsuno S., Okamoto H. Activation of Reg gene, a gene for insulin-producing β-cell regeneration: poly(ADP-ribose) polymerase binds Reg promoter and regulates the transcription by autopoly(ADP-ribosyl)ation. Proc. Natl. Acad. Sci. USA 2001, 98:48-53.
14. Yoshizumi M., Abe J., Haendeler J., Huang Q., Berk B.C. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J. Biol. Chem. 2000, 275:11706-11712.
15. Lu J.W., Lin Y.M., Chang J.G., Yeh K.T., Chen R.M., Tsai J.J.P., Su W.W., Hu R.M. Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma. Med. Oncol. 2013, 30:379.
16. Massagué J., Pandiella A. Membrane-anchored growth factors. Annu. Rev. Biochem. 1993, 62:515-541.
17. Wells A. EGF receptor. Int. J. Biochem. Cell Biol. 1999, 31:637-643.
18. Pinkas-Kramarski R., Soussan L., Waterman H., Levkowitz G., Alroy I., Klapper L., Lavi S., Seger R., Ratzkin B.J., Sela M., Yarden Y. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J. 1996, 15:2452-2467.
19. Wallasch C., Weiss F.U., Niederfellner G., Jallal B., Issing W., Ullrich A. Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J. 1995, 14:4267-4275.
20. Plowman G.D., Culouscou J.M., Whitney G.S., Green J.M., Carlton G.W., Foy L., Neubauer M.G., Shoyab M. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. USA 1993, 90:1746-1750.
21. Prabhakar N.R. Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J. Appl. Physiol. 2001, 90:1986-1994.
22. Schulz R., Mahmoudi S., Hattar K., Sibelius U., Olschewski H., Mayer K., Seeger W., Grimminger F. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am. J. Respir. Crit. Care Med. 2000, 162:566-570.
23. Dyugovskaya L., Lavie P., Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am. J. Respir. Crit. Care Med. 2002, 165:934-939.
24. Yamauchi M., Nakano H., Maekawa J., Okamoto Y., Ohnishi Y., Suzuki T., Kimura H. Oxidative stress in obstructive sleep apnea. Chest 2005, 127:1674-1679.
25. Basta G., Schmidt A.M., De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc. Res. 2004, 63:582-592.
26. Kojda G., Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc. Res. 1999, 43:562-571.
27. Yamanaka Y., Hayashi K., Komurasaki T., Morimoto S., Ogihara T., Sobue K. EGF family ligand-dependent phenotypic modulation of smooth muscle cells through EGF receptor. Biochem. Biophys. Res. Commun. 2001, 281:373-377.
28. Nanney L.B., Stoscheck C.M., King L.E. Characterization of binding and receptors for epidermal growth factor in smooth muscle. Cell Tissue Res. 1988, 254:125-132.
29. Tomita M., Hirata Y., Uchihashi M., Fujita T. Characterization of epidermal growth factor receptors in cultured vascular smooth muscle cells of rat aorta. Endocrinol. Jpn. 1986, 33:177-184.
30. Tamura R., Miyagawa J., Nishida M., Kihara S., Sasada R., Igarashi K., Nakata A., Yamamori K., Kameda-Takemura K., Yamashita S., Matsuzawa Y. Immunohistochemical localization of betacellulin, a member of epidermal growth factor family, in atherosclerotic plaques of human aorta. Atherosclerosis 2001, 155:413-423.
31. Dreux A.C., Lamb D.J., Modjtahedi H., Ferns G.A. The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis. Atherosclerosis 2006, 186:38-53.
32. Ryan S., McNicholas W.T., Taylor C.T. A critical role for p38 map kinase in NF-κB signaling during intermittent hypoxia/reoxygenation. Biochem. Biophys. Res. Commun. 2007, 355:728-733.
33. Ryan S., Taylor C.T., McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005, 112:2660-2667.
34. Semenza G.L. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 2009, 24:97-106.